Vicor Technologies, Inc.
2300 NW Corporate Boulevard
Suite 123
Boca Raton,
FL 33431
United States - Map
Phone: 561-995-7313
Fax: 561-995-2449
Web Site: http://www.vicortech.com
| Vicor Technologies, Inc., a medical diagnostics company, engages in the development of diagnostic and therapeutic products in the United States. Its diagnostic products are based on the companys patented PD2i algorithm, which is used to predict future pathological events, such as fatal cardiac arrhythmias, imminent death, and autonomic nervous system dysfunction. The company develops its therapeutic products by using a drug discovery platform, which focuses on naturally occurring biomolecules derived from state-dependent physiologies, such as hibernation. Vicor Technologies products include the PD2i Cardiac Analyzer that risk stratifies patients into those at high or low risk of suffering a fatal arrhythmic event, or sudden cardiac death within a six to twelve-month time frame; and PD2i-VS, which is used to assess the severity of injury of critically injured combat casualties to determine the need for an immediate life saving intervention in those trauma victims who are at high risk of imminent death. The companys products also comprise PD2i-Analyzer to diagnose diabetic autonomic neuropathy; and PD2iOR/ICU to utilize a change in the PD2i value as an early warning to surgeons and anesthesiologists of a sharply deteriorating condition in a patient during surgery and also facilitate the assessment of ICU patients being discharged to a step-down unit. It markets its products through in-house sale force and independent distributors to clinical cardiologists, electrophysiologists, family practitioners, and endocrinologists. Vicor Technologies has a collaboration agreement with University of Rochester and the U.S. Army Institute of Surgical Research, as well as an original equipment manufacturing agreement with Nasiff Associates Inc. to integrate its PD2i software into Nasiff's Cardio Card ECG. The company was founded in 2000 and is based in Boca Raton, Florida. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David H. Fater , 62
Chief Exec. Officer, Pres, Chief Financial Officer |
$
165.00K | N/A | Dr. Daniel N. Weiss M.D., F.A.C.C., 47
Chief Medical Officer and Member of Scientific Advisory Board |
$
180.00K | N/A | Dr. Jerry M. Anchin Ph.D., 49
VP, Director of R&D, Member of Scientific Advisory Board |
$
156.00K | N/A | Dr. James E. Skinner Ph.D., 67
VP, Director of R&D, Member of Scientific Advisory Board |
$
174.00K | N/A | Mr. Thomas J. Bohannon CPA, 64
Chief Accounting Officer and VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
0.01 (1.61%) 
Profile
